Skin care brands from South Korea have established themselves as a permanent fixture in many of our beauty routines, but just a bit east exists another hub that’s formulating game-changing ...

So it’s not shocking that prebiotic skin care products (aka formulas with key ingredients that serve as food for bacteria) are growing in popularity. “Prebiotic ingredients are substances ...

I tried some Western products and Korean skin care brands here and there, but nothing seemed to help, especially since I thought the best way to eliminate my blemishes was to extract them myself ...

As I’ve been working on these guides for skin care through each decade (you can read my guide to skin care in your teens, 40s, and 50s), I’ve learned that there are some priorities that remain ...

BioAge Labs filed confidentially on May 31, 2024. Goldman Sachs, Morgan Stanley, Jefferies, and Citi are the joint bookrunners on the deal. No pricing terms were disclosed.

Many things can cause red skin, from a simple sunburn to a potentially serious infection. Getting a proper diagnosis of the underlying cause is important for finding the most effective treatment.

The move comes months after BioAge raised $170 million in a funding round led by life sciences investment firm Sofinnova Investments. BioAge said it will list its shares on the Nasdaq under the ...

Like it or not, your skin changes as you age — but how do you know when you’ve reached the point of needing anti-aging skin care? Or when to start using products meant for mature skin?

The synthetic form of niacinamide is used in making moisturizers, serums, and other skin care products. Niacinamide vs. niacin Niacin, also called vitamin B3, is a type of B vitamin that ...

But that’s not to say that you can’t make a real difference in your skin with your skin-care routine at home. Below, I’ve drawn on my years of beauty reporting and chatted to over a dozen ...

Sept 3 (Reuters) - BioAge Labs, an obesity therapy-focused startup that has also collaborated with Eli Lilly (LLY.N), opens new tab, filed for an initial public offering in the United States on ...

BioAge Labs Inc, a biotech focused on developing therapies for metabolic diseases, filed an SEC filing to raise up to $100 million in an initial public offering.